Old Web
English
Sign In
Acemap
>
authorDetail
>
Esprit Ma
Esprit Ma
Tufts Medical Center
Medicine
Brentuximab vedotin
Cost-effectiveness analysis
Intensive care medicine
Autologous stem-cell transplantation
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland
2017
Journal of Medical Economics
Chris Parker
Bethan Sarah Woods
James Eaton
Esprit Ma
Ross Selby
Eugene Benson
Andreas Engstrom
Peter Sajosi
Andrew Briggs
Vijayveer Bonthapally
Show All
Source
Cite
Save
Citations (4)
A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
2016
Margaret Hux
Denise Zou
Esprit Ma
Peter Sajosi
Andreas Engstrom
Selby Ross
Eugene Benson
Andrew Briggs
Vijayveer Bonthapally
Show All
Source
Cite
Save
Citations (0)
1